CANCER RELATED COGNITIVE DECLINE

Clinical trials for CANCER RELATED COGNITIVE DECLINE explained in plain language.

Never miss a new study

Get alerted when new CANCER RELATED COGNITIVE DECLINE trials appear

Sign up with your email to follow new studies for CANCER RELATED COGNITIVE DECLINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug aims to shield patients from Chemo's hidden damage

Disease control Recruiting now

This early-stage study is testing if a drug called azeliragon can protect the heart and brain from damage caused by chemotherapy in women with early-stage breast cancer. Researchers will give azeliragon alongside standard chemotherapy to about 48 participants to see if it's safe …

Matched conditions: CANCER RELATED COGNITIVE DECLINE

Phase: PHASE1, PHASE2 • Sponsor: Georgetown University • Aim: Disease control

Last updated Apr 04, 2026 06:50 UTC

CANCER RELATED COGNITIVE DECLINE

Get alerted when new CANCER RELATED COGNITIVE DECLINE trials appear

New drug aims to shield patients from Chemo's hidden damage